National Holdings Corporation Announces Expansion of Capital Markets Team
August 20 2018 - 7:33AM
National Holdings Corporation (NASDAQ: NHLD) (“National” or the
“Company”), a leading full-service independent brokerage,
investment banking, trading insurance accounting and asset
management firm, today announced the expansion of its Capital
Markets team in Boston:
- Mark Berube has joined as Senior Vice President, Institutional
Equity Sales
- Thomas Durkin has also joined as Senior Vice President,
Institutional Equity Sales
Together, Mr. Berube and Mr. Durkin will be integral to
National’s continued expansion of its capital markets business and
geographic presence.
Michael Mullen, Chairman and Chief Executive Officer of
National, stated, “We are extremely pleased to have Mark and Tom
join our team. From our new Boston office, they will be integral in
growing National’s capital markets business. Mark and Tom will have
an immediate impact by adding key buy-side relationships and
enhancing our core institutional competencies."
Mr. Mullen added, “Biotechnology, Life Sciences, REITs and BDCs
are the largest segments of our banking business. As National
continues to evolve, expanding our corporate footprint into Boston
is the natural next step for us. We welcome both Mark and Tom to
the National family!”
About Mark Berube
Mark Berube joins National Securities after serving as a Vice
President at Drexel Hamilton, where he worked with Thomas Durkin to
establish the company’s Boston regional trading desk. Before this,
Mr. Berube was a Managing Director at GL Capital Partners, where he
managed sales and business development for the emerging asset
manager. Over the course of his career, Mr. Berube has also held
senior management positions at Weeden & Co., Think Equity,
Leerink Swann & Co., and Bear Sterns & Co. Mr. Berube
received his B.A. from Skidmore College and holds his Series 7, 55,
63 and 65 licenses.
About Thomas Durkin
Prior to joining National, Thomas Durkin was a Vice President at
Drexel Hamilton, where he worked with Mark Berube to open the
Boston regional trading desk for the company. Mr. Durkin also held
a Director position at Avondale Partners. Prior to this, Mr. Durkin
spent 10 years at Wedbush/Pacgrow Life Sciences, where he recruited
and opened the firm’s first regional equity trading desk in Boston.
He also held senior roles at BB&T Capital Markets, Weeden &
Co. and State Street Bank & Trust, where he was a key member of
each firm’s equity trading team. Mr. Durkin received his Master of
Science in Finance from Suffolk University and his B.A. in
Economics from the University of Massachusetts. He holds his Series
7, 55 and 63 licenses.
About National Holdings CorporationNational
Holdings Corporation (NASDAQ: NHLD) is a full-service investment
banking and asset management firm that, through its affiliates,
provides a range of services, including independent retail
brokerage and advisory services, investment banking, institutional
sales and trading, equity research, financial planning, market
making, tax preparation and insurance, to corporations,
institutions, high net-worth and retail investors. With over 1,000
advisors, registered reps, traders, sales associates and corporate
staff, National Holdings operates through various subsidiaries
including National Securities Corporation, National Asset
Management, Inc., National Insurance Corporation, Gilman Ciocia,
Inc. and GC Capital Corporation. Formed as a holding company in
1999, National Holdings’ largest subsidiary National Securities
Corporation has been in business since 1947. National Holdings is
headquartered in New York and Florida. For more information,
visit www.nhld.com. Fortress Biotech, Inc. (NASDAQ: FBIO)
through its affiliate FBIO Acquisition, Inc., is a majority
shareholder of NHLD.
FORWARD-LOOKING STATEMENTSThis press release
may contain certain forward-looking statements. Any such
statements, other than statements of historical fact, are based on
management’s current expectations, estimates, projections, beliefs
and assumptions about National Holdings, Inc., its current and
prospective portfolio investments, and its industry. These
statements are not guarantees of future performance and are subject
to risks, uncertainties and other factors, some of which are beyond
National Holdings, Inc.’s control, difficult to predict and could
cause actual results to differ materially from those expected or
forecasted in such forward-looking statements. Actual developments
and results are likely to vary materially from these estimates and
projections as a result of a number of factors, including those
described from time to time in National Holdings, Inc.’s filings
with the Securities and Exchange Commission. Such statements speak
only as of the time when made, and National undertakes no
obligation to update any such forward-looking statements, whether
as a result of new information, future events, or otherwise, except
as required by law.
CONTACTS:
MEDIA CONTACTEric Hazard for
National917-765-8720national@fullyvested.com
INVESTOR RELATIONSEmail:
ir@nhldcorp.com
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Sep 2023 to Sep 2024